Skip to main content

Table 2 MUC1 expression in endocervical and endometrial adenocarcinomas

From: Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma*

 

Median (range)

+ Cases/Total (%)1

 

ECA

EMMA

(p-value)

ECA

EMMA

(p-value)

Apical

35 (0–100)

15 (0–90)

NS

8/14 (57%)

7/18 (39%)

NS

A/C

0 (0–80)

70 (0–100)

<0.001

2/14 (14%)

14/18 (78%)

<0.001

Negative

35 (0–100)

0 (0–90)

0.01

7/14 (50%)

2/18 (11%)

0.01

  1. ECA, endocervical adenocarcinoma; EMMA, endometrial mucinous adenocarcinoma; A/C, apical/cytoplasmic; NS, not significant. 1 totals are >100% because different areas of tumors differed in staining pattern.
Back to article page

BMC Clinical Pathology

ISSN: 1472-6890

Contact us